Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Aug 11, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Read at PubMed CentralPubMed Central · Aug 11, 2026
C-MET tyrosine kinase receptor: mechanisms, clinical applications and future perspectives in cancer therapy.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Exosomes in Colorectal Cancer: From Tumor Biology to Diagnostic and Therapeutic Applications.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Proadrenomedullin N-Terminal 20 Peptide (PAMP) Increases Proliferation and Induces Cytoskeleton Remodeling in Melanoma Cells Through the CXCR7/CXCR4/β-Arrestin Axis.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Margin-enriched CD4(+) central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Immune modulation in gastric cancer: from macrophage polarization to immunotherapy.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune cocultures.
Read at PubMed CentralPubMed Central · Aug 11, 2026
GNG12 overexpression inhibits triple-negative breast cancer cell proliferation, migration, and invasion.
Read at PubMed CentralPubMed Central · Aug 11, 2026
AMOTL2 inhibits lymph node metastasis in gastric cancer by suppressing TGF-β/Smad signaling and is destabilized by the E3 ubiquitin ligase SMURF1.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Investigation and validation of prognostic features associated with transient receptor potential channel genes in gastric cancer.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Rethinking PDAC: from immunological silence to therapeutic opportunity.
Read at PubMed CentralPubMed Central · Aug 11, 2026
A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Preoperative Phase Angle as a Marker of Nutritional and Functional Vulnerability in Patients Undergoing Colorectal Cancer Surgery: A Prospective Observational Cohort Study.
Read at PubMed CentralPubMed Central · Aug 11, 2026
Structure-based screening and identification of a novel Aurora-A-targeting peptide with antiproliferative activity against prostate cancer cells.
Read at PubMed CentralPubMed Central · Aug 10, 2026
The circadian-microbiome-immune axis in colorectal cancer: mechanisms of spatiotemporal immunosuppression and chronotherapeutic horizons.
Read at PubMed CentralPubMed Central · Aug 10, 2026
miRNA484 and miRNA335-5p as Potential Diagnostic Biomarkers for CA19-9-Negative Pancreatic Ductal Adenocarcinoma.
Read at PubMed CentralPubMed Central · Aug 10, 2026
XYL-1 and Olaparib Synergistically Inhibit the Growth of Pancreatic Cancer by Suppressing the SCD1/BRCA1 Signaling Pathway.
Read at PubMed Central